David Charles Lubner Insider Trading $RARX Ra Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for David Charles Lubner.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of David Charles Lubner. David Charles Lubner is SVP and CFO in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and EVP & CFO in Ra Pharmaceuticals, Inc. ($RARX) and Executive V.P. & CFO in Ra Pharmaceuticals, Inc. ($RARX) and Executive VP and CFO in Ra Pharmaceuticals, Inc. ($RARX) and Director in Nightstar Therapeutics plc ($NITE) and Director in Vor Biopharma Inc. ($VOR) and Director in Gemini Therapeutics, Inc. /DE ($FSDC) and Director in Dyne Therapeutics, Inc. ($DYN).

David Charles Lubner in Ra Pharmaceuticals, Inc.

Trading Symbol: RARX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Charles Lubner: Executive VP and CFO, Executive V.P. & CFO, EVP & CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2020
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of David Charles Lubner in Ra Pharmaceuticals, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, DYN, FSDC, NITE, RARX, TTPH, VOR

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 03 2020	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive VP and CF ...	Option Exercise	D	0.00	10,416	0	0
Apr 03 2020	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive VP and CF ...	Option Exercise	D	21.00	133,000	2,793,000	0
Apr 03 2020	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive VP and CF ...	Option Exercise	D	7.33	62,500	458,125	0
Apr 03 2020	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive VP and CF ...	Option Exercise	D	16.64	112,500	1,872,000	0
Apr 03 2020	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive VP and CF ...	Option Exercise	D	5.60	28,571	159,998	0
Apr 03 2020	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive VP and CF ...	Option Exercise	D	2.87	92,283	264,852	0
Apr 03 2020	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive VP and CF ...	Option Exercise	D	2.87	115,572	331,692	0
Apr 03 2020	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive VP and CF ...	Sell	D	48.00	15,622	749,856	0	15.6 K to 0 (-100.00 %)
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	M	0.00	10,417	0	20,833
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	A	21.00	133,000	2,793,000	133,000
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Payment of Exercise	F	21.00	3,291	69,111	7,126	10.4 K to 7.1 K (-31.59 %)
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Buy	M	0.00	10,417	0	10,417	0 to 10.4 K
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	A	0.00	31,250	0	31,250
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	A	7.33	62,500	458,125	62,500
Feb 03 2017	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	A	16.64	112,500	1,872,000	112,500
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lubner David Charles	EVP & CFO	Option Exercise	A	2.87	29,285	84,048	29,285

Page: 1